So,if the case is not closed for cll trials then the company must be counting on partnership with deeper pockets than there own.That seems to be the reason that they didnt meet the confirmatory data that fda asked for,so that then the deeper pocketed company could be reassured that the fda had positive info on Gen./cll results to feel it was safe to buy into Genta.Thus not wasting there time and money.Thus enabling Genta to finance Agenda and Tesetaxel.I am trying to get a handle on the progression of events as I am a little confused as to the why they didnt meet fda confirmatory info they asked for.
If I knew for sure this was going to happen, yes I would have gotten out taking a loss even...avged at .0112..But on Monday getting back in for cheaper...unfortunately too late now for myself and many....It means now I have to budget myself better...but as long as company does its trials and no diluting takes place our nice futures will takes place....I hope...Good luck ...God bless to all who believe
News 
Market Data 
Discover 
AI
